Our findings also suggest that patients with elevated ALT (suggesting a degree of NAFLD) are at higher risk of additional hepatic inflammation, at least during the early stages of dietary restriction-based weight loss interventions. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.